Humana Inc (HUM) - Net Assets
Based on the latest financial reports, Humana Inc (HUM) has net assets worth $18.58 Billion USD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($49.72 Billion) and total liabilities ($31.14 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check HUM asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $18.58 Billion |
| % of Total Assets | 37.37% |
| Annual Growth Rate | 6.81% |
| 5-Year Change | 19.79% |
| 10-Year Change | 58.95% |
| Growth Volatility | 26.06 |
Humana Inc - Net Assets Trend (1990–2024)
This chart illustrates how Humana Inc's net assets have evolved over time, based on quarterly financial data. Also explore Humana Inc (HUM) total assets for the complete picture of this company's asset base.
Annual Net Assets for Humana Inc (1990–2024)
The table below shows the annual net assets of Humana Inc from 1990 to 2024. For live valuation and market cap data, see how much is Humana Inc worth.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $16.45 Billion | +0.78% |
| 2023-12-31 | $16.32 Billion | +6.17% |
| 2022-12-31 | $15.37 Billion | -4.55% |
| 2021-12-31 | $16.10 Billion | +17.30% |
| 2020-12-31 | $13.73 Billion | +14.05% |
| 2019-12-31 | $12.04 Billion | +18.46% |
| 2018-12-31 | $10.16 Billion | +3.24% |
| 2017-12-31 | $9.84 Billion | -7.89% |
| 2016-12-31 | $10.69 Billion | +3.28% |
| 2015-12-31 | $10.35 Billion | +7.26% |
| 2014-12-31 | $9.65 Billion | +3.54% |
| 2013-12-31 | $9.32 Billion | -46.36% |
| 2012-12-31 | $17.37 Billion | +115.40% |
| 2011-12-31 | $8.06 Billion | +16.45% |
| 2010-12-31 | $6.92 Billion | +19.88% |
| 2009-12-31 | $5.78 Billion | +29.59% |
| 2008-12-31 | $4.46 Billion | +10.63% |
| 2007-12-31 | $4.03 Billion | +31.93% |
| 2006-12-31 | $3.05 Billion | +23.43% |
| 2005-12-31 | $2.47 Billion | +18.37% |
| 2004-12-31 | $2.09 Billion | +13.84% |
| 2003-12-31 | $1.84 Billion | +14.28% |
| 2002-12-31 | $1.61 Billion | +6.53% |
| 2001-12-31 | $1.51 Billion | +10.88% |
| 2000-12-31 | $1.36 Billion | +11.80% |
| 1999-12-31 | $1.22 Billion | -27.94% |
| 1998-12-31 | $1.69 Billion | +27.98% |
| 1997-12-31 | $1.32 Billion | +2.09% |
| 1996-12-31 | $1.29 Billion | +0.39% |
| 1995-12-31 | $1.29 Billion | +21.64% |
| 1994-12-31 | $1.06 Billion | +19.01% |
| 1993-12-31 | $889.00 Million | -55.90% |
| 1992-12-31 | $2.02 Billion | +0.35% |
| 1991-12-31 | $2.01 Billion | +14.83% |
| 1990-12-31 | $1.75 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Humana Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 2113.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $28.32 Billion | 172.93% |
| Common Stock | $33.00 Million | 0.20% |
| Other Comprehensive Income | $-1.07 Billion | -6.52% |
| Total Equity | $16.38 Billion | 100.00% |
Humana Inc Competitors by Market Cap
The table below lists competitors of Humana Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
ZTE Corp
SHE:000063
|
$22.80 Billion |
|
Airports Of Thailand PCL
BK:AOT
|
$22.82 Billion |
|
PulteGroup Inc
NYSE:PHM
|
$22.91 Billion |
|
SAIC Motor Corp Ltd
SHG:600104
|
$22.94 Billion |
|
Kuehne + Nagel International AG
F:KNIU
|
$22.79 Billion |
|
Centrais Elétricas Brasileiras S.A. - Eletrobrás
SA:AXIA3
|
$22.78 Billion |
|
Mettler-Toledo International Inc
NYSE:MTD
|
$22.77 Billion |
|
Markel Corporation
NYSE:MKL
|
$22.77 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Humana Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 16,262,000,000 to 16,375,000,000, a change of 113,000,000 (0.7%).
- Net income of 1,207,000,000 contributed positively to equity growth.
- Dividend payments of 431,000,000 reduced retained earnings.
- Share repurchases of 817,000,000 reduced equity.
- Other comprehensive income decreased equity by 68,000,000.
- Other factors increased equity by 222,000,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $1.21 Billion | +7.37% |
| Dividends Paid | $431.00 Million | -2.63% |
| Share Repurchases | $817.00 Million | -4.99% |
| Other Comprehensive Income | $-68.00 Million | -0.42% |
| Other Changes | $222.00 Million | +1.36% |
| Total Change | $- | 0.69% |
Book Value vs Market Value Analysis
This analysis compares Humana Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.03x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 15.89x to 2.03x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1990-12-31 | $17.30 | $274.96 | x |
| 1991-12-31 | $12.79 | $274.96 | x |
| 1992-12-31 | $12.65 | $274.96 | x |
| 1993-12-31 | $5.49 | $274.96 | x |
| 1994-12-31 | $6.58 | $274.96 | x |
| 1995-12-31 | $7.82 | $274.96 | x |
| 1996-12-31 | $7.82 | $274.96 | x |
| 1997-12-31 | $9.05 | $274.96 | x |
| 1998-12-31 | $10.08 | $274.96 | x |
| 1999-12-31 | $7.56 | $274.96 | x |
| 2000-12-31 | $8.16 | $274.96 | x |
| 2001-12-31 | $9.01 | $274.96 | x |
| 2002-12-31 | $9.34 | $274.96 | x |
| 2003-12-31 | $11.32 | $274.96 | x |
| 2004-12-31 | $12.84 | $274.96 | x |
| 2005-12-31 | $15.00 | $274.96 | x |
| 2006-12-31 | $18.17 | $274.96 | x |
| 2007-12-31 | $23.72 | $274.96 | x |
| 2008-12-31 | $26.38 | $274.96 | x |
| 2009-12-31 | $34.16 | $274.96 | x |
| 2010-12-31 | $40.78 | $274.96 | x |
| 2011-12-31 | $48.04 | $274.96 | x |
| 2012-12-31 | $54.12 | $274.96 | x |
| 2013-12-31 | $58.54 | $274.96 | x |
| 2014-12-31 | $61.88 | $274.96 | x |
| 2015-12-31 | $68.45 | $274.96 | x |
| 2016-12-31 | $70.80 | $274.96 | x |
| 2017-12-31 | $67.60 | $274.96 | x |
| 2018-12-31 | $73.42 | $274.96 | x |
| 2019-12-31 | $89.34 | $274.96 | x |
| 2020-12-31 | $103.21 | $274.96 | x |
| 2021-12-31 | $124.27 | $274.96 | x |
| 2022-12-31 | $120.47 | $274.96 | x |
| 2023-12-31 | $130.68 | $274.96 | x |
| 2024-12-31 | $135.48 | $274.96 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Humana Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 7.37%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.02%
- • Asset Turnover: 2.53x
- • Equity Multiplier: 2.84x
- Recent ROE (7.37%) is below the historical average (12.61%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1990 | 17.70% | 6.38% | 1.23x | 2.25x | $134.64 Million |
| 1991 | 17.67% | 6.05% | 1.32x | 2.20x | $154.10 Million |
| 1992 | 6.09% | 3.03% | 1.07x | 1.87x | $-78.90 Million |
| 1993 | 10.01% | 2.84% | 1.81x | 1.95x | $100.00K |
| 1994 | 16.64% | 4.82% | 1.87x | 1.85x | $70.20 Million |
| 1995 | 14.76% | 4.04% | 1.63x | 2.24x | $61.30 Million |
| 1996 | 0.93% | 0.18% | 2.15x | 2.44x | $-117.20 Million |
| 1997 | 11.53% | 2.15% | 1.48x | 3.61x | $22.90 Million |
| 1998 | 7.64% | 1.31% | 1.80x | 3.26x | $-39.84 Million |
| 1999 | -30.16% | -3.74% | 2.08x | 3.86x | $-509.22 Million |
| 2000 | 6.62% | 0.85% | 2.54x | 3.06x | $-45.95 Million |
| 2001 | 7.77% | 1.15% | 2.32x | 2.92x | $-33.62 Million |
| 2002 | 8.89% | 1.27% | 2.45x | 2.86x | $-17.89 Million |
| 2003 | 12.19% | 1.83% | 2.31x | 2.88x | $40.14 Million |
| 2004 | 13.40% | 2.14% | 2.32x | 2.71x | $71.00 Million |
| 2005 | 12.47% | 2.14% | 2.10x | 2.78x | $61.07 Million |
| 2006 | 15.96% | 2.28% | 2.11x | 3.32x | $182.03 Million |
| 2007 | 20.69% | 3.30% | 1.96x | 3.20x | $430.79 Million |
| 2008 | 14.52% | 2.24% | 2.22x | 2.93x | $201.44 Million |
| 2009 | 18.00% | 3.36% | 2.19x | 2.45x | $462.07 Million |
| 2010 | 15.87% | 3.27% | 2.09x | 2.33x | $406.59 Million |
| 2011 | 17.60% | 3.85% | 2.08x | 2.20x | $612.70 Million |
| 2012 | 13.81% | 3.12% | 1.96x | 2.26x | $337.30 Million |
| 2013 | 13.21% | 2.98% | 1.99x | 2.23x | $299.40 Million |
| 2014 | 11.89% | 2.36% | 2.06x | 2.44x | $182.40 Million |
| 2015 | 12.33% | 2.35% | 2.20x | 2.39x | $241.40 Million |
| 2016 | 5.75% | 1.13% | 2.14x | 2.38x | $-454.50 Million |
| 2017 | 24.87% | 4.55% | 1.98x | 2.76x | $1.46 Billion |
| 2018 | 16.56% | 2.96% | 2.24x | 2.50x | $666.90 Million |
| 2019 | 22.49% | 4.17% | 2.23x | 2.42x | $1.50 Billion |
| 2020 | 24.53% | 4.36% | 2.21x | 2.55x | $1.99 Billion |
| 2021 | 18.24% | 3.53% | 1.87x | 2.76x | $1.32 Billion |
| 2022 | 18.33% | 3.02% | 2.16x | 2.81x | $1.27 Billion |
| 2023 | 15.31% | 2.34% | 2.26x | 2.89x | $862.80 Million |
| 2024 | 7.37% | 1.02% | 2.53x | 2.84x | $-430.50 Million |
Industry Comparison
This section compares Humana Inc's net assets metrics with peer companies in the Healthcare Plans industry.
Industry Context
- Industry: Healthcare Plans
- Average net assets among peers: $8,262,291,222
- Average return on equity (ROE) among peers: -10.11%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Humana Inc (HUM) | $18.58 Billion | 17.70% | 1.68x | $22.79 Billion |
| Alignment Healthcare LLC (ALHC) | $158.07 Million | -93.64% | 2.74x | $3.66 Billion |
| Cigna Corp (CI) | $13.79 Billion | 13.54% | 3.31x | $75.89 Billion |
| Clover Health Investments Corp (CLOV) | $-54.83 Million | 0.00% | 0.00x | $1.00 Billion |
| Centene Corp (CNC) | $25.96 Billion | 10.41% | 2.26x | $19.48 Billion |
| CVS Health Corp (CVS) | $9.92 Billion | 13.80% | 1.07x | $101.04 Billion |
| Elevance Health Inc (ELV) | $23.29 Billion | 11.36% | 1.29x | $63.54 Billion |
| Molina Healthcare Inc (MOH) | $64.76 Million | 46.52% | 1.31x | $6.97 Billion |
| Marpai Inc (MRAI) | $-27.71 Million | 0.00% | 0.00x | $6.04 Million |
| NeueHealth Inc (NEUE) | $1.27 Billion | -93.04% | 1.83x | $60.94 Million |
About Humana Inc
Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. It offers medical care and supplemental benefit plans to individuals. The company also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with … Read more